- R&D
New York University Study Finds Prominent Breakthrough for Pain Management; Outperforms Pain Drug
Researchers at New York University have made an important discovery in the field of pain management, revealing a potential paradigm shift. Their...EnginZyme Utilizes Biocatalysis to Manufacture Essential Component for mRNA Vaccines
Mohsin Riaz - 0EnginZyme AB, a cutting-edge technology company specializing in enzymatic biomanufacturing, has successfully patented a revolutionary process for producing pseudouridine, a critical component...Labcorp Unveils Breakthrough Blood Test for Alzheimer’s Diagnosis and Neurodegenerative Disease Detection
Labcorp has introduced a novel blood test aimed at aiding the diagnosis of Alzheimer's disease, further enhancing its range of services in...Overcoming Age-Related Challenges in Nanodrug Delivery for Pediatric Cancer Patients
The efficacy of medical treatments often varies with age, and this principle holds true in the world of nanodrug delivery for pediatric,...
- Clinical
Merck’s Evobrutinib Encounters Setbacks in MS Trials Amid BTK Inhibitor Challenges
Merck KGaA's foray into the competitive BTK inhibitor space has hit a roadblock, with its highly-touted contender, Evobrutinib, failing to surpass Sanofi's...Merus Faces Setback Following Interim Report for Lung Cancer Therapy
Merus, a biopharmaceutical company, confronted a significant setback following an interim report on the progress of MCLA-129, a bispecific therapy designed for...Lung Cancer Data from AbbVie Paves Way for Accelerated ADC Approval, Falls Below Initial Benchmark
AbbVie is actively seeking accelerated approval for its promising c-Met antibody-drug conjugate (ADC), Teliso-V. In the recent update from the Luminosity trial,...In a late-stage trial, GSK’s blood cancer medication achieves its main objective
GlaxoSmithKline (GSK) has achieved a significant breakthrough in its efforts to enhance its oncology business with the blood cancer drug, Blenrep, reaching...
- Manufacturing
Novo Nordisk announces €2.1 billion commitment to France
Novo Nordisk has announced a substantial investment of €2.1 billion to expand its production facility in Chartres, located to the south-west of...Lilly plans to construct a $2.5 billion manufacturing facility in Germany
Eli Lilly, a U.S.-based pharmaceutical company, has announced plans to construct its first manufacturing facility in Germany, specifically in the town of...Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency
Merck has solidified a substantial collaboration valued at $490 million with Ginkgo Bioworks, aimed at revolutionizing the landscape of biologics manufacturing. This...Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies
Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a new joint manufacturing facility in Portsmouth, New Hampshire. The primary...
- Commercial
Roche’s $2.7 Billion Move into the Obesity Market Acquisition of Carmot Therapeutics
Roche has made a resounding entry into the obesity market with a whopping upfront investment of $2.7 billion. This strategic move comes...AstraZeneca’s Strategic Leap into KRAS G12D with Chinese Biotech Collaboration
AstraZeneca has secured a significant deal in the competitive field of cancer research, specifically focusing on a target known as KRAS G12D....GSK Drops Bowel Disease Asset Amid Immunology Unit Changes
GlaxoSmithKline (GSK) has jolted the pharmaceutical community with its abrupt decision to sever ties with Sosei Heptares, a move that comes just...
- Technology
Microscopic “super bots” repair neural wound model
In a recent development, scientists have brought science fiction to life by creating miniature biological robots, known as biobots, capable of healing...Amgen Expands Amazon Partnership to Seek Generative AI Solutions
In a concerted effort to enhance the discovery and manufacturing processes of pharmaceuticals, Amgen is broadening its longstanding alliance with the technology...Siemens Healthineers & Qure.ai partnership Aims to Enhance Tuberculosis Diagnosis Using AI
Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Combat AIDS, Tuberculosis, and Malaria, is spearheading an initiative to expedite...Philips Launches New Platform to Improve Health Monitoring
Over two years following the acquisition of the medical information aggregator Capsule Technologies, Philips is introducing an innovative integrated information platform. This...
- Regulatory
Lilly’s Jaypirca leads the leukemia trail with FDA approval
In the highly competitive landscape of BTK inhibitors for blood cancer treatment, Eli Lilly has set itself apart by gaining approval from...FDA Expresses Doubt Over Merck’s Cough Candidate
Merck & Co. is racing against the clock to launch the first medication for chronic coughing on the market. With the FDA...After success with its BabySat system, Owlet gains FDA clearance for its Dream Sock
Owlet, the innovative baby monitoring system company, is celebrating a significant milestone as it secures FDA clearance for its Dream Sock technology....Federal Court Rejects Alvogen’s Bid for FDA Approval of Bausch’s Xifaxan Version
Salix Pharmaceuticals, a subsidiary of Bausch Health, has emerged victorious in its ongoing legal battle to protect its medication Xifaxan, used to...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
- R&D
New York University Study Finds Prominent Breakthrough for Pain Management; Outperforms Pain Drug
Researchers at New York University have made an important discovery in the field of pain management, revealing a potential paradigm shift. Their...EnginZyme Utilizes Biocatalysis to Manufacture Essential Component for mRNA Vaccines
Mohsin Riaz - 0EnginZyme AB, a cutting-edge technology company specializing in enzymatic biomanufacturing, has successfully patented a revolutionary process for producing pseudouridine, a critical component...Labcorp Unveils Breakthrough Blood Test for Alzheimer’s Diagnosis and Neurodegenerative Disease Detection
Labcorp has introduced a novel blood test aimed at aiding the diagnosis of Alzheimer's disease, further enhancing its range of services in...Overcoming Age-Related Challenges in Nanodrug Delivery for Pediatric Cancer Patients
The efficacy of medical treatments often varies with age, and this principle holds true in the world of nanodrug delivery for pediatric,...
- Clinical
Merck’s Evobrutinib Encounters Setbacks in MS Trials Amid BTK Inhibitor Challenges
Merck KGaA's foray into the competitive BTK inhibitor space has hit a roadblock, with its highly-touted contender, Evobrutinib, failing to surpass Sanofi's...Merus Faces Setback Following Interim Report for Lung Cancer Therapy
Merus, a biopharmaceutical company, confronted a significant setback following an interim report on the progress of MCLA-129, a bispecific therapy designed for...Lung Cancer Data from AbbVie Paves Way for Accelerated ADC Approval, Falls Below Initial Benchmark
AbbVie is actively seeking accelerated approval for its promising c-Met antibody-drug conjugate (ADC), Teliso-V. In the recent update from the Luminosity trial,...In a late-stage trial, GSK’s blood cancer medication achieves its main objective
GlaxoSmithKline (GSK) has achieved a significant breakthrough in its efforts to enhance its oncology business with the blood cancer drug, Blenrep, reaching...
- Manufacturing
Novo Nordisk announces €2.1 billion commitment to France
Novo Nordisk has announced a substantial investment of €2.1 billion to expand its production facility in Chartres, located to the south-west of...Lilly plans to construct a $2.5 billion manufacturing facility in Germany
Eli Lilly, a U.S.-based pharmaceutical company, has announced plans to construct its first manufacturing facility in Germany, specifically in the town of...Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency
Merck has solidified a substantial collaboration valued at $490 million with Ginkgo Bioworks, aimed at revolutionizing the landscape of biologics manufacturing. This...Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies
Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a new joint manufacturing facility in Portsmouth, New Hampshire. The primary...
- Commercial
Roche’s $2.7 Billion Move into the Obesity Market Acquisition of Carmot Therapeutics
Roche has made a resounding entry into the obesity market with a whopping upfront investment of $2.7 billion. This strategic move comes...AstraZeneca’s Strategic Leap into KRAS G12D with Chinese Biotech Collaboration
AstraZeneca has secured a significant deal in the competitive field of cancer research, specifically focusing on a target known as KRAS G12D....GSK Drops Bowel Disease Asset Amid Immunology Unit Changes
GlaxoSmithKline (GSK) has jolted the pharmaceutical community with its abrupt decision to sever ties with Sosei Heptares, a move that comes just...
- Technology
Microscopic “super bots” repair neural wound model
In a recent development, scientists have brought science fiction to life by creating miniature biological robots, known as biobots, capable of healing...Amgen Expands Amazon Partnership to Seek Generative AI Solutions
In a concerted effort to enhance the discovery and manufacturing processes of pharmaceuticals, Amgen is broadening its longstanding alliance with the technology...Siemens Healthineers & Qure.ai partnership Aims to Enhance Tuberculosis Diagnosis Using AI
Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Combat AIDS, Tuberculosis, and Malaria, is spearheading an initiative to expedite...Philips Launches New Platform to Improve Health Monitoring
Over two years following the acquisition of the medical information aggregator Capsule Technologies, Philips is introducing an innovative integrated information platform. This...
- Regulatory
Lilly’s Jaypirca leads the leukemia trail with FDA approval
In the highly competitive landscape of BTK inhibitors for blood cancer treatment, Eli Lilly has set itself apart by gaining approval from...FDA Expresses Doubt Over Merck’s Cough Candidate
Merck & Co. is racing against the clock to launch the first medication for chronic coughing on the market. With the FDA...After success with its BabySat system, Owlet gains FDA clearance for its Dream Sock
Owlet, the innovative baby monitoring system company, is celebrating a significant milestone as it secures FDA clearance for its Dream Sock technology....Federal Court Rejects Alvogen’s Bid for FDA Approval of Bausch’s Xifaxan Version
Salix Pharmaceuticals, a subsidiary of Bausch Health, has emerged victorious in its ongoing legal battle to protect its medication Xifaxan, used to...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
Editor Picks
Fresh Tracks Set to Dissolve with no Buyer in the Pipeline
After months of looking into various other possibilities, Fresh Tracks Therapeutics has...
FDA not confident in GSK’s therapy for rectal cancer
There has been a lot of media coverage that showed keen interest...
The Changing Role of a Histotechnologist
Ask a doctor to describe a typical day’s work and her answer...
Must Read
Merck’s Evobrutinib Encounters Setbacks in MS Trials Amid BTK Inhibitor Challenges
Merck KGaA's foray into the competitive BTK inhibitor space has hit a...
Lilly’s Jaypirca leads the leukemia trail with FDA approval
In the highly competitive landscape of BTK inhibitors for blood cancer treatment,...
Merus Faces Setback Following Interim Report for Lung Cancer Therapy
Merus, a biopharmaceutical company, confronted a significant setback following an interim report...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com